Raptor Pharmaceutical Corp Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
Raptor Pharmaceutical Corp had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $220.25 million as of 2014-03-31, per its 10-Q filed 2014-05-09.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2014-05-12
- 2014-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $220.25M.
- 2013-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $205.35M.
- 2013-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $193.26M.
- 2013-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $175.99M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) as first filed |
|---|---|---|
| 2014-03-31 | $220.25M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $205.35M 10-Q · filed 2014-05-09 | |
| 2013-09-30 | $193.26M 10-Q/A · filed 2014-05-12 | |
| 2013-06-30 | $175.99M 10-Q/A · filed 2014-05-12 | |
| 2013-03-31 | $151.87M 10-Q/A · filed 2014-05-12 | |
| 2012-12-31 | $135.94M 10-Q/A · filed 2014-05-12 | |
| 2012-11-30 | $130.04M 10-Q · filed 2013-01-09 | |
| 2012-08-31 | $116.65M 10-KT/A · filed 2014-05-12 | |
| 2012-05-31 | $106.42M 10-Q · filed 2012-07-10 | |
| 2012-02-29 | $103.43M 10-Q · filed 2012-04-09 | |
| 2011-11-30 | $89.43M 10-Q · filed 2012-01-06 | |
| 2011-08-31 | $78.00M 10-KT/A · filed 2014-05-12 | $78.00M 10-Q · filed 2012-01-06 |